Clinical Trials Browser

Interventional × Delirium × Clear all

NCT03021486 2026-03-18

Haloperidol With or Without Chlorpromazine in Treating Delirium in Patients With Advanced, Metastatic, or Recurrent Cancer

Phase 2/3 Active not recruiting

70 enrolled 20 charts

Delirium, Neoplasm Metastasis, Recurrence

NCT06256354 2026-03-09

Effects of Intraoperative Targeted Temperature Management on Incidence of Postoperative Delirium and Long-term Survival

Phase NA Recruiting

Delirium, Hypothermia

NCT01949662 2026-02-13

Haloperidol and Lorazepam for Delirium in Patients With Advanced Cancer

Phase 2 Active not recruiting

93 enrolled 14 charts

Other hematologic neoplasm

Delirium, Hematologic Neoplasms, Neurotoxicity Syndromes

NCT03012984 2026-01-08

Dexmedetomidine Supplemented Analgesia and Incidence of Postoperative Delirium

Phase NA Completed

Agnosia, Delirium, Postoperative Complications

NCT03743649 2025-12-26

Haloperidol and Lorazepam in Controlling Symptoms of Persistent Agitated Delirium in Patients With Advanced Cancer Undergoing Palliative Care

Phase 2/3 Active not recruiting

Delirium, Neoplasm Metastasis, Recurrence

NCT05834569 2025-09-05

Impact of Maxigesic on Delirium After Minimally Invasive Lung Surgery in Elderly Patients

Phase 4 Terminated

Emergence Delirium, Delirium, Lung Neoplasms

NCT04532606 2025-07-30

Impact of Remimazolam on Prognosis After Bladder Cancer Surgery

Phase 4 Recruiting

Emergence Delirium, Urinary Bladder Neoplasms, Delirium

NCT06834386 2025-05-01

Suvorexant for Insomnia to Prevent Delirium in Hospitalized Cancer Patients

Phase 4 Withdrawn

Delirium, Sleep Initiation and Maintenance Disorders

NCT02662257 2022-03-04

Impact of Anesthesia Maintenance Methods on Incidence of Postoperative Delirium

Phase NA Completed

Postoperative Cognitive Complications, Delirium, Neoplasms, Postoperative Complications

NCT03200600 2021-07-13

Dexamethasone, Flurbiprofen Axetil and Delirium After Lung Cancer Surgery

Phase 4 Terminated

Carcinoma, Non-Small-Cell Lung, Delirium

NCT04399343 2021-01-28

DEPOD

Phase 4 Unknown

Central Nervous System Diseases, Delirium

NCT04494828 2021-01-12

Impact Dexmedetomidine on Postoperative Delirium in Patients After Intracranial Operation for Brain Tumor

Phase 4 Completed

Central Nervous System Diseases, Delirium

NCT04516174 2020-08-18

Effect of Transversus Abdominis Plane Block Combined With Dexmedetomidine Infusion on the Prognosis in Elderly Patients Undergoing Abdominal Surgery

Phase NA Unknown

Gastrointestinal

Delirium, Pain, Postoperative, Colorectal Neoplasms

NCT03360474 2018-05-31

Implementation of a Delirium Screening

Phase NA Withdrawn

Delirium, Neoplasms

NCT01539733 2017-04-07

Early Recognition and Optimal Treatment of Delirium in Patients With Advanced Cancer

Phase NA Completed

Delirium

NCT00006349 2016-07-13

Donepezil and Vitamin E to Prevent Side Effects Caused By Radiation Therapy to the Head in Patients Receiving Treatment for Small Cell Lung Cancer

Phase 3 Completed

Delirium, Depression, Lung Neoplasms, Radiation Injuries, Small Cell Lung Carcinoma

NCT01687751 2015-05-25

Pilot Study Comparing Treatment With Dexmedetomidine to Midazolam for Symptom Control in Advanced Cancer Patients

Phase 2 Withdrawn

Death, Delirium, Dyspnea, Nausea, Neoplasms, Pain, Intractable